{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:44:23Z","timestamp":1763621063121,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lfs.2021.120073","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T14:08:43Z","timestamp":1634825323000},"page":"120073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparative study on the effect of aspirin, TP receptor antagonist and TxA2 synthase inhibitor on the vascular tone of human saphenous vein and internal mammary artery"],"prefix":"10.1016","volume":"286","author":[{"given":"Gulsev","family":"Ozen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Aljesri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Norel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsum","family":"Turky\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayg\u0131n","family":"Turky\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokce","family":"Topal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2021.120073_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCRESAHA.115.307937","article-title":"Coronary artery disease and its risk factors: leveraging shared genetics to discover novel biology","volume":"118","author":"Quertermous","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.lfs.2021.120073_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5761\/atcs.ra.16-00178","article-title":"Conduits used in coronary artery bypass grafting: a review of morphological studies","volume":"23","author":"Martinez-Gonzalez","year":"2017","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"year":"2021","author":"Bachar","series-title":"Coronary Artery Bypass Graft","key":"10.1016\/j.lfs.2021.120073_bb0015"},{"key":"10.1016\/j.lfs.2021.120073_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cct.2018.03.008","article-title":"Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909)","volume":"68","author":"Kulik","year":"2018","journal-title":"Contemp. Clin. Trials."},{"issue":"3","key":"10.1016\/j.lfs.2021.120073_bb0025","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.athoracsur.2015.09.071","article-title":"Spasm in arterial grafts in coronary artery bypass grafting surgery","volume":"101","author":"He","year":"2016","journal-title":"Ann. Thorac. Surg."},{"issue":"Suppl","key":"10.1016\/j.lfs.2021.120073_bb0030","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2021.120073_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.prostaglandins.2017.03.003","article-title":"Prostanoids in the pathophysiology of human coronary artery","volume":"133","author":"Ozen","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"4","key":"10.1016\/j.lfs.2021.120073_bb0040","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/pr.120.019331","article-title":"CIX. Differences and similarities between human and rodent prostaglandin E2 receptors (EP1-4) and prostacyclin receptor (IP): specific roles in pathophysiologic conditions","volume":"72","author":"Norel","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2021.120073_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00109-010-0621-6","article-title":"Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion","volume":"88","author":"Gabrielsen","year":"2010","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.lfs.2021.120073_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.prostaglandins.2017.11.004","article-title":"Role of thromboxane A2 signaling in endothelium-dependent contractions of arteries","volume":"134","author":"Chen","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.lfs.2021.120073_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106476","article-title":"Mechanism of thromboxane receptor-induced vasoconstriction in human saphenous vein","volume":"151","author":"Ozen","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.lfs.2021.120073_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejcts.2008.03.023","article-title":"Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent","volume":"34","author":"Zimmermann","year":"2008","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"1","key":"10.1016\/j.lfs.2021.120073_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2013.03.005","article-title":"ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without \"aspirin dilemma\"","volume":"132","author":"Sakata","year":"2013","journal-title":"Thromb. Res."},{"issue":"9510","key":"10.1016\/j.lfs.2021.120073_bb0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.lfs.2021.120073_bb0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jacc.2010.08.650","article-title":"Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery","volume":"57","author":"Gluckman","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120073_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002615","article-title":"Risk factors for nonplatelet thromboxane generation after coronary artery bypass graft surgery","volume":"5","author":"Kakouros","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.lfs.2021.120073_bb0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1538-7933.2004.00639.x","article-title":"Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist","volume":"2","author":"Osende","year":"2004","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.lfs.2021.120073_bb0090","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1538-7836.2011.04446.x","article-title":"The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin","volume":"9","author":"Fontana","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"22","key":"10.1016\/j.lfs.2021.120073_bb0095","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1111\/bph.13939","article-title":"Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI2: a safer alternative to COX-2 inhibition","volume":"174","author":"Ozen","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120073_bb0100","article-title":"Comparative study of coronary artery bypass graft materials: reduced contraction and ADMA levels in internal mammary artery versus saphenous vein","author":"Ozen","year":"2021","journal-title":"J. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.lfs.2021.120073_bb0105","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.HYP.0000127438.39744.07","article-title":"Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries","volume":"43","author":"Bolla","year":"2004","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.lfs.2021.120073_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.CCM.0000292155.06797.62","article-title":"Effects of aspirin, nimesulide, and SC-560 on vasopressin-induced contraction of human gastroepiploic artery and saphenous vein","volume":"36","author":"Aldasoro","year":"2008","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.lfs.2021.120073_bb0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1476-5381.2011.01264.x","article-title":"Differential reactivity of human mammary artery and saphenous vein to prostaglandin E(2): implication for cardiovascular grafts","volume":"163","author":"Foudi","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.lfs.2021.120073_bb0120","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.117.027597","article-title":"Mechanisms, consequences, and prevention of coronary graft failure","volume":"136","author":"Gaudino","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2021.120073_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1167\/iovs.05-0760","article-title":"Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries","volume":"47","author":"Vysniauskiene","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2021.120073_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jop.1998.14.119","article-title":"Effects of prostaglandin E2, F2alpha, and latanoprost acid on isolated ocular blood vessels in vitro","volume":"14","author":"Astin","year":"1998","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2021.120073_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(96)00870-9","article-title":"Histamine-induced contraction of human isolated bronchus is enhanced by endogenous prostaglandin F2 alpha and activation of TP receptors","volume":"319","author":"Knight","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2021.120073_bb0140","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1096\/fj.201801064RR","article-title":"TP and\/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F2alpha in mice and\/or humans","volume":"33","author":"Liu","year":"2019","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.lfs.2021.120073_bb0145","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1096\/fj.201901611R","article-title":"Prostaglandin E2 sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.lfs.2021.120073_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005344-200208000-00011","article-title":"Thromboxane A2 in vasomotor effects of phenylephrine, acetylcholine, and bradykinin in rat mesenteric bed","volume":"40","author":"Ben Cheikh","year":"2002","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120073_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2017.03.060","article-title":"Decreased vasorelaxation induced by iloprost during acute inflammation in human internal mammary artery","volume":"804","author":"Foudi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120073_bb0160","first-page":"135","article-title":"Effect of aspirin on the contractility of aortic rings in vitro from spontaneously hypertensive rats","volume":"20","author":"Rahmani","year":"1993","journal-title":"Artery"},{"issue":"28","key":"10.1016\/j.lfs.2021.120073_bb0165","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.2174\/092986710792231978","article-title":"Thromboxane synthase inhibitors and thromboxane A2 receptor antagonists: a quantitative structure activity relationships (QSARs) analysis","volume":"17","author":"Kontogiorgis","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2021.120073_bb0170","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.1991.tb12303.x","article-title":"The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery","volume":"103","author":"Templeton","year":"1991","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2021.120073_bb0175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bjp.0706121","article-title":"Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products","volume":"144","author":"Pannirselvam","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2021.120073_bb0180","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/bja\/aen074","article-title":"Endogenous antimicrobial peptide LL-37 induces human vasodilatation","volume":"100","author":"Berkestedt","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.lfs.2021.120073_bb0185","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00005344-199310000-00004","article-title":"Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis","volume":"22","author":"Schumacher","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2021.120073_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0741-5214(90)90099-V","article-title":"The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency","volume":"12","author":"Bech","year":"1990","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.lfs.2021.120073_bb0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1254\/jjp.66.471","article-title":"Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of Guinea pigs","volume":"66","author":"Higo","year":"1994","journal-title":"Jpn. J. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:54:14Z","timestamp":1758401654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521010602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S0024320521010602"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120073","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study on the effect of aspirin, TP receptor antagonist and TxA2 synthase inhibitor on the vascular tone of human saphenous vein and internal mammary artery","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120073"}}